top of page

Archive

Insight of Electric Fields Therapy

These articles section encompasses more than just articles about ECCT. It aimed to educate and provide insights about general electric field therapy application from a wide array of source worldwide, including news, opinions, research findings, educational content, professional advice, and more.

Section Title

Role of Electric Fields in Integrated Complementary Cancer Therapy

The article explores the potential of electric fields as a novel and promising approach in integrated complementary cancer therapy, emphasizing their advantages over conventional therapies, the challenges associated with current cancer treatments, and the need for continued research to optimize the application of electric fields in cancer therapy.

Wire-Mesh Capacitance Tomography for Treatment Planning System of Electro-Capacitive Cancer Therapy

Brain cancer stands as one of the most formidable and challenging types of cancer to combat. However, a recent breakthrough in research has introduced a novel approach in its treatment utilizing electric fields. This innovative method, termed electro-capacitive cancer therapy (ECCT), presents a non-invasive alternative devoid of the adverse effects commonly associated with traditional treatments like chemotherapy or radiation. ECCT operates by applying an electric field to the tumor region via a specialized helmet. This field disrupts the growth and multiplication of cancerous cells while leaving healthy cells unaffected.

A Novel Method for Measurement of Electric Field in Emulated Human Body Tissue using Wire Mesh Sensor

The study introduces a fresh technique for measuring electric fields, potentially upgrading treatment planning for therapies reliant on electric fields. This innovation holds promise in boosting the effectiveness of such treatments for cancer patients. Ultimately, it could revolutionize how we utilize electric fields in cancer treatment, paving the way for significant improvements in patient care.

Cox Model Survival Analysis to Evaluate Treatment of Electro-Capacitive Cancer Therapy (ECCT) For Cancer Patients

The research highlights the significance of monitoring frequency in ECCT's impact on the lifespan of patients with breast, brain, and lung cancers. It suggests that each extra monitoring session can potentially reduce the risk of death by 10-20%. In essence, this study underscores ECCT's potential effectiveness as a treatment option for cancer patients.

A Novel Method for Analyzing Electric Field Distribution of Electro Capacitive Cancer Treatment (ECCT) Using Wire Mesh Electrodes: A Case Study of Brain Cancer Therapy

The study indicates the potential effectiveness of ECCT as a treatment for individuals with brain cancer. It offers valuable insights into measuring and leveraging electric fields for cancer therapy.

Design of frequency generator and amplifier level converter using 300nm CMOS technology (2016 International Symposium on Electronics and Smart Devices (ISESD))

The study contributes to enhancing ECCT systems by incorporating Integrated Circuit technology. This integration has the potential to significantly enhance the efficiency and effectiveness of the system in treating cancer.

Electric Field-Based Cancer Therapy Induces the Expression of HMGB1 and PD-L1 mRNA Genes on Breast Tumor of Female Rats

The study observed that exposing breast tumor samples in rats to electric fields led to increased activity in specific genes, potentially influencing the tumor's behavior. Additionally, it demonstrated the safety of ECCT for healthy organs, particularly the brain and liver, in female rats.

Antiproliferative Effect of Electric Fields on Breast Tumor Cells In Vitro and In Vivo

The study shows ECCT stands as a potential novel approach for treating breast cancer. This therapy employs low-intensity, intermediate-frequency electric fields and has exhibited promising outcomes in both laboratory experiments and trials conducted on mice. Research indicated that ECCT not only slowed the growth of cancer cells but also halted the growth of some cells entirely.

Evaluation of Static Electric Field Exposure on Histopathological Structure and Function of Kidney and Liver in DMBA- Induced RAT

The study demonstrates that ECCT is not only safe for the liver and kidneys but also spares normal cells from harm. This stands as a significant advantage, addressing a key challenge in cancer treatment—how to target cancer cells without harming healthy ones. The research shows that, in rats, kidney and liver functions declined over time with chemotherapy alone, whereas those receiving ECCT did not experience the same deterioration.

CCL2 and IL18 expressions may associate with the anti-proliferative effect of noncontact electro capacitive cancer therapy in vivo

ECCT, by potentially reducing the activity of specific genes within breast tumor cells, holds promise in slowing down their growth. This implication positions ECCT as a potentially groundbreaking approach in the treatment of breast cancer, offering a new avenue for combating this disease.

Cytotoxic T cells response with decreased CD4/CD8 ratio during mammary tumors inhibition in rats induced by non-contact electric fields

This approach isn't just about slowing tumor growth; it also plays a significant role in bolstering the body's natural immune response against the tumor. By leveraging this method, there's a dual benefit—restraining the tumor's expansion while empowering the body's defense mechanisms to better combat and potentially suppress the cancerous growth.

Electric Field Distribution Measurement for electrocapacitive cancer therapy by using Wire Mesh Tomography

Major strides have been made in brain cancer treatment through the application of electricity. This study delves into a groundbreaking approach using electricity to specifically address brain cancer. Envision a treatment that is safer, more efficient, and less distressing. This research lays the groundwork for innovations that have the potential to profoundly change lives.

Effects of Non-Contact Electric Fields on Kidney and Liver Histology in Tumour-Induced Rats

Scientists conducted trials testing a new non-contact method of treating cancer using weak electric fields. These fields, harmless to normal cells, possess the ability to impede the growth and division of cancer cells by affecting their internal structures. In their study, rats with chemically induced breast cancer were exposed to varying strengths of these electric fields. Subsequently, the researchers examined the rats' kidneys and livers to assess any potential damage caused by the electric fields. Encouragingly, they found no harm inflicted on these organs and even noted a potential positive impact on kidney function in healthy rats. Based on their findings, the scientists concluded that the electric fields are safe for the kidney and liver in rats with breast cancer, advocating further research into optimizing their application and mechanism of action.

Numerical Analysis of Electric Force Distribution on Tumor Mass

Researchers have explored a pioneering approach to cancer treatment involving continuous, one-directional electric fields. These steady electric fields exert pressures on tumor cells, either propelling or retracting them. Using a computer model, scientists measured the electric force acting on tumor cells within breast cancer tissue. They evaluated two scenarios: one with a uniform distribution of the electric field across the tissue and another concentrating more powerfully on the tumor cells. Results highlighted a significantly higher electric force on the tumor cells compared to normal cells, further intensifying when the electric field specifically targeted the tumor cells. These findings led researchers to suggest that electric fields could potentially eliminate tumor cells by inducing their rupture or bursting.

Relative Expression of IL-10 and TNF-α mRNA of Kidney and Spleen Tissues

Researchers have investigated a groundbreaking cancer treatment approach employing electric fields with varying direction and strength. These low-intensity electric fields, harmless to normal cells, disrupt the growth and division of cancer cells by influencing their internal structures. In a study involving rats with chemically induced breast cancer, the subjects were exposed to different electric field strengths. Assessments of two molecules linked to inflammation and immune response in the kidney and spleen indicated no adverse effects on these organs. Notably, there were signs that the electric fields might mitigate inflammation and enhance immune response in rats with breast cancer. The researchers concluded that electric fields are safe for the kidney and spleen in rats with breast cancer, underscoring the necessity for further studies to optimize their application and understand their mechanisms.

Electric Field Distribution Analysis of Blood Cancer

The paper presents electric fields as a novel and effective treatment for blood cancer, a serious condition arising from the abnormal growth of white blood cells. The authors highlighted the impact of various factors—electrode size, shape, material, and voltage—on the electric field distribution in blood. Their suggestion is to use electrodes with high voltage and small size, generating robust electric fields capable of eliminating cancer cells through dielectrophoresis or electrochemical processes. This method holds promise as a potentially safer and more cost-effective alternative to other treatments.

The Specificity and Efficacy of Alternating Electric Fields as a Prospective Cancer Treatment

Advancements in medical technology are opening up new possibilities for cancer treatment. Specifically, the use of external electric fields has shown potential in inhibiting cancer growth. Devices such as Tumor Treating Fields (TTFields), nanosecond Pulsed Electric Fields (nsPEF), picosecond Pulsed Electric Fields (psPEF), and Electro-Capacitive Cancer Therapy (ECCT) are being studied and developed for this purpose. Among these, ECCT has been particularly effective and is being closely investigated, especially in breast cancer treatment.

Educate, not kill: treating cancer without triggering its defenses

This paper highlights the limitations of traditional cytotoxic therapies and the emergence of resistant cells, leading to therapy failure. Alternative therapeutic strategies, such as controlling cell dormancy, transdifferentiation therapy, normalizing the cancer microenvironment, and migrastatic therapy, are proposed as effective approaches to re-educate cancer cells towards a less malignant phenotype. These strategies aim to avoid inducing direct proliferative advantages to resistant cells, thereby delaying or preventing the development of therapy-resistant tumors. Therefore, alternative therapies are crucial for improving cancer treatment outcomes.

Alternating Electric Fields in Glioblastomas: Past, Present, and Future

Alternating electric fields is a new and noninvasive treatment method for glioblastomas, a type of deadly brain cancer. This therapy has shown promising results, including prolonged survival for patients and manageable side effects. It works by strengthening the body’s own immune response against the tumor, increasing the permeability of cell membranes and the blood-brain barrier, and disrupting the processes that repair DNA damage in cancer cells. However, despite these promising results, the acceptance of alternating electric fields in everyday clinical practice is still low. The paper calls for more studies and discussions to better understand the potential of alternating electric fields and to address any concerns that may be limiting its use in real-world settings. In simple terms, alternating electric field is a promising new treatment for a type of brain cancer, but more work needs to be done to make it a common practice in clinics. It’s an exciting development in cancer treatment, but as with all new treatments, it’s important to continue researching and understanding its full potential and limitations.

Alternating Electric Fields Therapy Concomitant with Taxanes for Cancer Treatment

Certain types of cancers, like non-small cell lung cancer, ovarian cancer, and pancreatic cancer, are often treated with chemotherapy. However, these treatments can cause harmful side effects. There’s a need for additional therapies that can improve the effectiveness of these treatments without increasing the side effects. One such therapy is alternating electric field, which uses electric fields to disrupt the growth of cancer cells. The study suggests that using electric field therapy along with chemotherapy could potentially improve cancer treatment effectiveness without increasing side effects. This could be a promising step forward in cancer treatment.

Disruption of Cancer Cell Replication by Alternating Electric Fields

Electric fields hold potential as a therapy for cancer, particularly for blood cancers characterized by spherical suspended cells. The paper elucidates how electric fields can disrupt the cell division process, inflicting damage on cancer cells. This study aims to encourage further research and advancements in electrostatic therapy, presenting a non-invasive, cost-effective, and targeted alternative to conventional treatments.

Electrical Characterization of Normal and Cancer Cells

The study delves into a captivating investigation aiming to differentiate between normal and cancer cells within liver, lung, and breast tissues. Using a set of parameters based on capacitance-voltage, researchers pinpointed unique electrical signatures for these cells. This pioneering method introduces novel prospects for recognizing and distinguishing normal and cancer cells based on their individual electrical signals. These findings offer potential advancements in diagnostic techniques, enhancing our capability to differentiate between healthy and cancerous cells across various tissue types.

Calculation of Externally Applied Electric Field Intensity for Disruption of Cancer Cell Proliferation

Electric fields present a promising avenue for cancer therapy, particularly for blood cancers characterized by spherical suspended cells. The paper elucidates how these fields can disrupt the cell division process, inflicting harm on cancerous cells. This study aims to stimulate further exploration and advancement in electrostatic therapy, envisioning a non-invasive, cost-effective, and targeted alternative to traditional treatments.

An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas

Recent advancements of alternating electric fields therapy demonstrate potential in prolonging survival without the common side effects associated with traditional chemotherapy. This presents a promising prospect for a treatment that is both more effective and easier for patients to tolerate. As research continues, the idea of combining alternating electric field with other anti-cancer approaches emerges as a potential strategy to further boost effectiveness. Understanding these developments is essential for patients, caregivers, and the broader community, instilling hope and encouraging support for ongoing research aimed at improving outcomes for individuals with glioblastoma.

Permeabilizing Cell Membranes with Electric Fields

Alternating electric fields therapy stands as a promising non-invasive cancer treatment, known for its minimal side effects. This innovative therapy disrupts cancer cell division without inducing considerable systemic toxicity, presenting a hopeful avenue for a more manageable and potent approach to cancer treatment.

The schemes, mechanisms and molecular pathway changes of Electric Field

This research emphasizes the potential of electric fields in combating cancer cells by disrupting their functions, leading to cell death and inhibiting their growth. The efficacy of this treatment hinges on several factors, including the frequency, intensity, duration, and direction of the electric field. Furthermore, when combined with other treatments like radiotherapy or chemotherapy, electric fields often exhibit a synergistic effect, enhancing their overall effectiveness. Overall, this offers a new ray of hope, particularly for patients whose cancers show resistance to traditional treatment methods.

Alternating Electric Fields: a new frontier in cancer therapy

Alternating electric fields therapy stands as a promising non-invasive cancer treatment, known for its minimal side effects. This innovative therapy disrupts cancer cell division without inducing considerable systemic toxicity, presenting a hopeful avenue for a more manageable and potent approach to cancer treatment.

Alternating Electric Fields Technology: Alternating Electric Field Therapy for the Treatment of Solid Tumors

alternating electric fields therapy offer a novel strategy in combating cancer by utilizing electric fields. They possess the capability to halt the growth and spread of cancer cells while preserving normal cells from harm. Electric field are user-friendly, entail minimal side effects, and complement other treatment modalities effectively.

Alternating Electric Fields: A Fourth Modality in Cancer Treatment

Electric Field based Tumor-treating fields represent a promising, novel approach in cancer treatment, employing electric fields to specifically target cancer cells while sparing normal ones. These fields are non-invasive, yield minimal side effects, and when combined with other therapies, show potential to enhance treatment outcomes.

How Do Alternating Electric Fields Work?

Scientists have devised a novel approach to cancer treatment using electric fields. These fields, though extremely mild, have no detrimental impact on healthy cells; however, they possess the ability to impede the growth and division of cancer cells by influencing their internal structures. Administering these electric fields to the tumor site involves a device capable of adjusting the strength and orientation of the fields based on the cancer type. Extensive testing in both animals and humans across various cancer types has demonstrated favorable outcomes, including tumor reduction, extended survival rates, and improved patient quality of life. Notably, these electric fields have minimal side effects and synergize effectively with other treatments like surgery, chemotherapy, and radiation therapy. They possess a unique mechanism for eliminating cancer cells, distinct from conventional treatments, and can be tailored to target specific cancer cell types.

Research Progress on the Mechanism of Anti-Tumor Immune Response Induced by Alternating Electric fields

Cancer is a deadly disease that affects millions of people worldwide. Many treatments have been developed to fight cancer, but they often have serious side effects or limited effectiveness. A new technology uses electric fields to stop cancer cells from growing and spreading. Researchers have found that alternating electric field not only kill cancer cells directly, but also activate the body’s own immune system to fight cancer. This is important because the immune system can recognize and destroy cancer cells that escape other treatments. This review summarizes the current knowledge on this topic and discusses the potential benefits and challenges of combining alternating electric field with other therapies that boost the immune system.

Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors

Researchers have uncovered the effectiveness of low-intensity, intermediate-frequency alternating electric fields in halting the growth of cancer cells. This innovative method has undergone rigorous testing, proving successful in lab settings (in vitro), animal trials (in vivo), and even in a select group of human patients battling recurrent glioblastoma, a formidable brain tumor. The outcomes are nothing short of remarkable, revealing a substantial increase in the time to disease progression and overall survival rates, all while maintaining minimal side effects. This groundbreaking discovery not only offers hope for those facing challenging forms of cancer but also signifies a promising stride toward more effective and less intrusive treatment options.

Alternating electric fields can improve chemotherapy treatment efficacy in blood cancer cell U937 (non-adherent cells)

Revolutionary strides in cancer treatment are unfolding through innovative methods. A recent study has unveiled a promising approach by combining alternating electric fields with the chemotherapy agent Daunorubicin, showcasing enhanced efficacy in treating blood cancer cells, particularly the non-adherent U937 cells. This cutting-edge technique selectively targets dividing cancer cells while sparing normal cells, potentially paving the way for reduced side effects in patients. It's crucial to acknowledge that these findings are preliminary, and further research is imperative to solidify their impact. As always, individuals are advised to consult their healthcare providers for personalized guidance based on their unique health circumstances. This research signifies a significant leap forward in the relentless pursuit of more effective and targeted cancer treatments.

Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study

Advancements in alternating electric fields can significantly improve the survival rates of patients with metastatic non-small cell lung cancer (mNSCLC) who have not responded to platinum-based chemotherapy. This study shows that combining alternating electric field therapy with standard-of-care treatments can lead to better outcomes compared to standard-of-care treatments alone.

Research Progress on the Mechanism of Anti-Tumor Immune Response Induced by TTFields

The article reviews the progress of research on the mechanism of anti-tumor immune response induced by Tumor Treating Fields (TTFields). TTFields has been approved for the treatment of glioblastomas and malignant pleural mesotheliomas. It highlights that TTFields have shown promising effects as a monotherapy and in combination with chemotherapy, but the underlying mechanisms through, which TTFields exert their anticancer effects remain incompletely understood. Recent research suggests that inducing anti-tumor immune responses may be a key mechanism of the anticancer activity of TTFields, leading to several clinical trials exploring the combination of TTFields with tumor immunotherapy and achieving positive results. The article also discusses the potential mechanisms through which TTFields induce anti-tumor immune responses, including enhancing immune cell infiltration and function, inducing immunogenic cell death in tumor cells, regulating immune-related signaling pathways, and upregulating immune checkpoints in tumor cells. Furthermore, the clinical significance of TTFields in activating and enhancing anti-tumor immune responses is highlighted, showing potential improvements in patient survival and quality of life. The combination of TTFields with immune checkpoint inhibitors has shown unprecedented therapeutic effects in clinical practice, indicating the promising clinical application prospects of TTFields. However, the document emphasizes the need for further research to clarify the molecular mechanisms of TTFields in anti-tumor therapy, potentially overcoming the problem of low sensitivity to radiotherapy and chemotherapy and enhancing the therapeutic outcomes of TTFields. Overall, the review provides a comprehensive overview of the progress and potential of TTFields in activating anti-tumor immune responses and improving clinical outcomes in cancer therapy.

The distinguishing electrical properties of cancer cells

This paper explores the unique electrical properties of cancer cells, shedding light on the complex network of factors that contribute to the development of cancer. It challenges the
traditional view of cancer as solely a genetic disease and emphasizes the importance of understanding the electrostatic changes in cancer cells compared to normal cells. By exploring the
effects of alterations in intracellular and extracellular pH, changes in ionic concentrations, variations in transmembrane potential, and modifications within mitochondria, the paper provides a comprehensive understanding of the electrical landscape of cells. Additionally, it discusses the potential implications of these electrical properties for novel cancer treatment modalities, such as electromagnetic field-based therapies. The research aims to pave the way for a new paradigm in understanding the role of electrical properties in health and disease, with the potential to revolutionize therapeutic interventions.

bottom of page